Heart health in women—especially during perimenopause and menopause—is evolving quickly. Newer cholesterol guidelines are shifting the conversation away from simply “waiting until someone has heart disease” and toward identifying risk earlier, looking at the whole picture, and treating preventively for the long term.
For many women, menopause is a major turning point for cardiovascular health.
As estrogen declines, we often see changes in:
- LDL (“bad”) cholesterol
- Visceral fat accumulation
- Blood sugar and insulin resistance
- Blood pressure
- Inflammation
- Sleep quality and stress resilience
These changes can quietly increase cardiovascular risk—even in women who “look healthy” on standard labs.
Newer Guidelines: Looking Beyond Basic Cholesterol
The updated 2026 ACC/AHA dyslipidemia guidance emphasizes a more personalized and proactive approach.
Instead of only looking at total cholesterol, clinicians are increasingly evaluating:
- LDL-C
- ApoB
- Lipoprotein(a) [Lp(a)]
- Triglycerides
- Non-HDL cholesterol
- Metabolic health and body composition
Risk-enhancing factors matter too:
- Prediabetes or insulin resistance
- PCOS
- Autoimmune disease
- Chronic stress
- Poor sleep or sleep apnea
- Hypertension
- Smoking
- Visceral fat
- Pregnancy complications like preeclampsia or gestational hypertension
Interestingly, pregnancy is now viewed as an early “stress test” for future cardiovascular risk in women.
What About Coronary Calcium Scores?
Coronary artery calcium (CAC) scoring can help personalize decisions around treatment.
A CAC score of:
- 0 may support delaying medication in some patients
- 1–99 may favor treatment, especially over age 55
- >100 suggests more aggressive prevention is warranted
This can be particularly helpful for women who fall into a “gray zone” where standard risk calculators may underestimate risk.
Statins: More Nuanced Than Many People Think
The updated guidelines continue to support statins when appropriate—but the conversation is becoming more individualized.
For women with elevated risk, treatment may include:
- Lifestyle and nutrition changes
- Statins
- Ezetimibe
- Bempedoic acid
- PCSK9 inhibitors in higher-risk patients
And importantly: there are often ways to improve tolerability if side effects occur. Sometimes adjusting the dose, switching medications, or using alternate-day dosing can help.
Lifestyle Still Matters—A Lot
One of the most powerful takeaways from the newer guidelines is that metabolic health matters deeply for cardiovascular prevention.
Foundational strategies include:
- Mediterranean-style nutrition
- Reducing refined carbohydrates
- Prioritizing protein and fiber
- Strength training and muscle building
- Blood sugar stabilization
- Sleep optimization
- Reducing alcohol intake
Continuous glucose monitors (CGMs) are also increasingly being used as short-term tools to help patients understand how food, stress, sleep, and exercise affect blood sugar regulation.
Menopause Hormone Therapy and Heart Health
This remains an evolving area of research, but modern menopause medicine is increasingly recognizing that appropriately timed hormone therapy may play an important role in cardiovascular protection for some women.
The conversation is far more nuanced than it was years ago—and individualized risk assessment matters.
The Bigger Picture
At Tendwell, we believe cardiovascular prevention should not be reduced to a single cholesterol number.
Heart health is connected to:
- inflammation
- metabolic function
- hormones
- sleep
- nervous system regulation
- body composition
- stress physiology
The goal is not simply to “normalize labs,” but to better understand why risk is increasing and create a personalized strategy that supports long-term health and vitality.